ZA976196B - Peptide reagent for the detection of human cytomegalovirus (cmv) - Google Patents

Peptide reagent for the detection of human cytomegalovirus (cmv)

Info

Publication number
ZA976196B
ZA976196B ZA976196A ZA976196A ZA976196B ZA 976196 B ZA976196 B ZA 976196B ZA 976196 A ZA976196 A ZA 976196A ZA 976196 A ZA976196 A ZA 976196A ZA 976196 B ZA976196 B ZA 976196B
Authority
ZA
South Africa
Prior art keywords
cmv
detection
antibodies
human cytomegalovirus
peptide reagent
Prior art date
Application number
ZA976196A
Other languages
English (en)
Inventor
Johannes Martinus Ger Crommert
Jaap Michiel Middeldorp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA976196B publication Critical patent/ZA976196B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA976196A 1996-07-12 1997-07-11 Peptide reagent for the detection of human cytomegalovirus (cmv) ZA976196B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12

Publications (1)

Publication Number Publication Date
ZA976196B true ZA976196B (en) 1998-09-01

Family

ID=8224180

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976196A ZA976196B (en) 1996-07-12 1997-07-11 Peptide reagent for the detection of human cytomegalovirus (cmv)

Country Status (12)

Country Link
US (1) US6936251B2 (de)
EP (1) EP0960336B1 (de)
JP (1) JP4218985B2 (de)
KR (1) KR100624517B1 (de)
AT (1) ATE225942T1 (de)
AU (1) AU735981B2 (de)
DE (1) DE69716305T2 (de)
DK (1) DK0960336T3 (de)
ES (1) ES2187796T3 (de)
ID (1) ID19063A (de)
WO (1) WO1998002746A1 (de)
ZA (1) ZA976196B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919121B4 (de) * 1999-04-27 2012-08-02 F. Hoffmann-La Roche Ag Multimeres CMV-Antigen
EP1328540B1 (de) 2000-10-20 2005-03-23 City of Hope Immunoreaktive peptidische ctl-epitope aus dem menschlichen cytomegalovirus pp150
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
ITMI20012160A1 (it) * 2001-10-18 2003-04-18 Edoardo Marchisio Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
CA2677455A1 (en) * 2007-02-07 2008-08-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Recombinant antigens of human cytomegalovirus (hcmv)
DK2352759T3 (en) 2008-07-16 2017-12-18 Inst Res Biomedicine ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
WO2010148541A1 (zh) * 2009-06-26 2010-12-29 鑫品生医科技股份有限公司 含衍生自细胞巨大病毒的胜肽的免疫原组成物及使用方法
JP5712513B2 (ja) * 2010-07-07 2015-05-07 富士レビオ株式会社 ヒトサイトメガロウイルス感染の検出方法
NZ591514A (en) * 2011-03-03 2013-11-29 Kode Biotech Ltd Assay method
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽
CN116298269A (zh) * 2022-08-17 2023-06-23 浙江大学医学院附属第一医院 人类巨细胞病毒重组抗原特异性IgG抗体的酶联免疫检测试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590656B2 (en) * 1985-12-06 1989-11-09 Teijin Limited Anti cytomegaloviral human monoclonal antibody and process for its preparation
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
EP0330051B1 (de) * 1988-02-24 1996-01-03 BEHRINGWERKE Aktiengesellschaft Strukturelles Phosphoprotein (pp28) des menschlichen Cytomegalovirus (HCMV), seine Herstellung und Verwendung
GB9014652D0 (en) * 1990-07-02 1990-08-22 Wellcome Found Antigen
DE4128684A1 (de) * 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
US5744298A (en) * 1991-08-29 1998-04-28 Behringwerke Aktiengesellschaft DNA sequences which encode immunoreactive HCMV-specific peptides
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
DE4426453C1 (de) * 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits
EP0702083A3 (de) * 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien

Also Published As

Publication number Publication date
US20030119039A1 (en) 2003-06-26
US6936251B2 (en) 2005-08-30
AU735981B2 (en) 2001-07-19
EP0960336B1 (de) 2002-10-09
AU3623197A (en) 1998-02-09
JP2000514300A (ja) 2000-10-31
EP0960336A1 (de) 1999-12-01
DK0960336T3 (da) 2003-02-10
KR100624517B1 (ko) 2006-09-18
ID19063A (id) 1998-06-11
WO1998002746A1 (en) 1998-01-22
KR20000023701A (ko) 2000-04-25
JP4218985B2 (ja) 2009-02-04
DE69716305D1 (de) 2002-11-14
ES2187796T3 (es) 2003-06-16
ATE225942T1 (de) 2002-10-15
DE69716305T2 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
ZA976196B (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
EP1104887A3 (de) Verfahren und Testsatz zur Bestimmung von Kollagenfragmenten in Körperflüssigkeiten
WO2001086306A3 (en) Affinity selected signature peptides for protein identification and quantification
SE9500023D0 (sv) Method of detecting cancer
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
WO2002008767A3 (en) Methods and kits for sequencing polypeptides
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
AU5479396A (en) Epstein-Barr virus peptides and antibodies against these peptides
AU2002223044A1 (en) Kit and method for detecting the esm-1 protein
DE69821246D1 (de) Testverfahren für collagenpeptid
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
WO1995014778A3 (en) Dna sequence coding for a bmp receptor
EP1652918A3 (de) Verfahren zum Nachweis von Protein-Interaktionen basierend auf Peptiden mit beschraenkten Konformationen
WO2000007024A3 (en) Method of protein analysis
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
DK0607425T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
WO2001015655A3 (en) Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
NO994056L (no) Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav
AU6642698A (en) Immunoassay and kit for iga antibodies specific for acetaldehyde adducts
ATE271067T1 (de) An menschliches wachstumshormon (hgh) bindende monoklonale antikörper
FI20002225A7 (fi) Diagnostinen menetelmä